Commission européenne, DG COMP MERGER REGISTRY, 1049 Bruxelles, BELGIQUE  
Europese Commissie, DG COMP MERGER REGISTRY, 1049 Brussel,   BELGIË  
 
Tel: +32 229- 91111. Fax: +32 229 -64301. E -mail: COMP -MERGER -REGISTRY@ec.europa.eu.  
  EUROPEAN COMMISSION  
Brussels, 27.08.2020  
C(2020)  5954 final  
PUBLIC VERSION 
To the notifying parties  
Subject : Case M. 9877– PRO DIAGNOSTIC GROUP / FUTURELIFE / DISCARE 
CZ JV  
Commission decision pursuant to Article 6(1)(b) of Council Regulation 
(EC) No  139/20041 and Article 57 of the Agreement on the European 
Economic Area2  
Dear Sir or Madam,  
1. On 3 August 2020, the European Commission received notification of a proposed 
concentration pursuant to Article 4 of the Merger  Regulation by which Pro Diagnostic 
Group, a.s (“PDG”, Slovakia), controlled by Ribera Salud Infraestructuras, S.L.U. 
(Spain) and Pro Partners Holding, a.s. (Slovakia) , and FutureLife a.s. (“FutureLife”, 
Czechia), ultimately controlled by Mr. Zbyněk Průša , acquire within the meaning of 
Artic les 3(1)(b) and 3(4) of the Merger Regulation joint control of  the undertaking 
DISCARE a.s. (‘‘JV’’, Czechia). The concentration is accomplished by way of 
purchase of shares in a newly created company constituting a joint venture.3 
2. The business activities of the undertakings concerned are:  
− for PDG: it operates 12 diagnostic imaging centres in private health facilities in 
Slovakia in the Magnetic Resonance Imaging , X-Ray, Computed Tomography / 
Positron Emission Tomography and Ultrasonography modalities;  
− for FutureLife: active in the provision of healthcare services and laboratories. The 
FutureLife group companies mainly operate healthcare clinics providing services 
in the field of assisted reproduction in central Europe. Some group companies 
also operate outp atient and inpatient clinics specialized in medical care in areas 
such as rheumatology, andrology, venous surgery, gastroenterology, urology, 
treatment of Crohn’s disease and other inflammatory bowel diseases, and plastic 
surgery;  
                                                 
1 OJ L 24, 29.1.2004, p. 1 ( the ‘Merger Regulation ’). With effect from 1 December 2009,  the Treaty on 
the Functioning of the European Union ( ‘TFEU ’) has introduced certain changes, such as the 
replacement of ‘Community ’ by ‘Union’  and ‘common market ’ by ‘internal market ’. The terminology 
of the TFEU will be used throughout th is decision.  
2  OJ L 1, 3.1.1994, p.  3 (the ‘EEA Agreement ’). 
3  Publication in the Official Journal of the European Union No C 261, 10.8.2020, p. 2. 

2 − for the JV:  it will operate a diagnostic imaging centre offering X -Ray and 
Magnetic R esonance Imaging  services in Prague.  
3. After examination of the notification, the European Commission has concluded that 
the notified operation falls within the scope of the Merger  Regulation and of 
paragraph 5(a) and 5( c) of the Commission Notice on a simplified procedure for 
treatment of certain concentrations under Council Regulation (EC) No  139/2004.4 
4. For the reasons set out in the Notice on a simplified procedure, the European 
Commission has decided not to oppose the notified operation and to declare it 
compatible with the internal market and with the EEA Agreement. This decision is 
adopted in application of Article 6(1)(b) of the Merger  Regulation  and Article 57 of 
the EEA Agre ement . 
For the Commission 
 
 
(Signed)  
Olivier GUERSENT  
Director -General  
                                                 
4  OJ C 366, 14.12.2013, p. 5.